Inventor · disambiguated record
Yuan-Tsong Chen
Also filed as: CHEN YUAN-TSONG
25 granted patents·14 pending applications·155 citations·filing 1999–2023
96Inventor score
Top patents by PatentIndex Score
39 records- 0194US8900552B2Treatment of glycogen storage disease type IICHEN YUAN-TSONG·Filed 2012·Granted Dec 2, 2014·18 cites·13 claims
- 0292US11214782B2Method of treating glycogen storage disease type VIUNIV DUKE·Filed 2020·Granted Jan 4, 2022·3 cites·14 claims
- 0391US7056712B2Treatment of glycogen storage disease type IIUNIV DUKE·Filed 2001·Granted Jun 6, 2006·22 cites·21 claims
- 0489US10647969B2Method of treating glycogen storage disease type IX using acid alpha-glucosidaseUNIV DUKE·Filed 2017·Granted May 12, 2020·3 cites·12 claims
- 0587US9907839B2Treatment of glycogen storage disease type IIUNIV DUKE·Filed 2016·Granted Mar 6, 2018·3 cites·17 claims
- 0686US9370556B2Treatment of glycogen storage disease type IIUNIV DUKE·Filed 2014·Granted Jun 21, 2016·4 cites·16 claims
- 0785US8012686B2Risk assessment for adverse drug reactionsACADEMIA SINICA·Filed 2008·Granted Sep 6, 2011·3 cites·16 claims
- 0884US7470513B2Risk assessment for adverse drug reactionsACADEMIA SINICA·Filed 2003·Granted Dec 30, 2008·11 cites·6 claims
- 0983US9850474B2Methods for treating glycogen storage disease type IV usng lysosomal acid alpha-glucosidaseUNIV DUKE·Filed 2015·Granted Dec 26, 2017·3 cites·15 claims
- 1083US7666405B2Deleted adenovirus vectors and methods of making and administering the sameUNIV DUKE·Filed 2004·Granted Feb 23, 2010·13 cites·21 claims
- 1182US8142999B2HLA alleles associated with adverse drug reactions and methods for detecting suchCHEN YUAN-TSONG·Filed 2011·Granted Mar 27, 2012·3 cites·8 claims
- 1281US10792341B2Treatment of glycogen storage disease type IIUNIV DUKE·Filed 2018·Granted Oct 6, 2020·1 cites·2 claims
- 1381US9428575B2Anti-granulysin antibodies and methods of use thereofDEV CT BIOTECHNOLOGY·Filed 2013·Granted Aug 30, 2016·5 cites·13 claims
- 1480US9050333B2Method of treating glycogen storage disease type III with human acid α-glucosidaseCHEN YUAN-TSONG·Filed 2009·Granted Jun 9, 2015·3 cites·9 claims
- 1577US7943309B2HLA alleles associated with adverse drug reactions and methods for detecting suchPHARMIGENE INC·Filed 2007·Granted May 17, 2011·3 cites·8 claims
- 1677US6328958B1Deleted adenovirus vectors and methods of making and administering the sameUNIV DUKE·Filed 1999·Granted Dec 11, 2001·44 cites·37 claims
- 1777US2021169996A1Treatment of Glycogen Storage Disease Type IIUNIV DUKE·Filed 2020·Application pending·0 cites
- 1876US7718378B2Granulysin and uses thereofACADEMIA SINICA·Filed 2007·Granted May 18, 2010·2 cites·6 claims
- 1975US8377436B2Granulysin and uses thereofACADEMIA SINICA·Filed 2010·Granted Feb 19, 2013·2 cites·5 claims
- 2075US6797265B2Deleted adenovirus vectors and methods of making and administering the sameUNIV DUKE·Filed 2001·Granted Sep 28, 2004·9 cites·75 claims
- 2174US2022106579A1Method of Treating Glycogen Storage DiseaseUNIV DUKE·Filed 2021·Application pending·0 cites
- 2271US2010254966A1Treatment of glycogen storage disease type iiUNIV DUKE·Filed 2009·Application pending·0 cites
- 2366US2008175833A1Treatment of glycogen storage disease type IIUNIV DUKE·Filed 2007·Application pending·0 cites
- 2466US2023243810A1Composition and method for modulating fibroblast growth factor receptor 3 activationACADEMIA SINICA·Filed 2023·Application pending·0 cites
- 2562US2012077192A1Risk Assessment For Adverse Drug ReactionsCHEN YUAN-TSONG·Filed 2011·Application pending·0 cites
- 2660US2005123531A1Treatment of glycogen storage disease type IIUNIV DUKE·Filed 2005·Application pending·0 cites
- 2759US2012058132A1Treatment of glycogen storage disease type IICHEN YUAN-TSONG·Filed 2011·Application pending·0 cites
- 2858US7964351B2Risk assessment for adverse drug reactionsACADEMIA SINICA·Filed 2008·Granted Jun 21, 2011·0 cites·8 claims
- 2957US9562268B2Risk assessment for adverse drug reactionsACADEMIA SINICA·Filed 2013·Granted Feb 7, 2017·0 cites·1 claims
- 3054US11630102B2Composition and method for modulating fibroblast growth factor receptor 3 activationACADEMIA SINICA·Filed 2018·Granted Apr 18, 2023·0 cites·4 claims
- 3154US9797015B2Genetic variants associated with lithium response in bipolar disorderACADEMIA SINICA·Filed 2014·Granted Oct 24, 2017·0 cites·12 claims
- 3252US2005277587A1CD7 as biomarker and therapeutic target for psoriasisACADEMIA SINICA·Filed 2004·Application pending·0 cites
- 3348US2006166239A1Genetic variants predicting warfarin sensitivityACADEMIA SINICA·Filed 2005·Application pending·0 cites
- 3446US2007298426A1Warfarin dosage predictionACADEMIA SINICA·Filed 2007·Application pending·0 cites
- 3546US2008305474A1Method and Apparatus for Using SLC2A10 Genetic Polymorphisms for Determining Peripheral Vascular Disease in Patients with Type-2 DiabetesCHEN YUAN-TSONG·Filed 2007·Application pending·0 cites
- 3641US8927462B2Method for identifying HLA complexes associated with adverse drug reactionsCHEN YUAN-TSONG·Filed 2011·Granted Jan 6, 2015·0 cites·19 claims
- 3740US10983133B2Diagnosis and treatment of Kawasaki diseaseACADEMIA SINICA·Filed 2015·Granted Apr 20, 2021·0 cites·8 claims
- 3840US2011236885A1Genetic Variants Predicting Warfarin SensitivityACADEMIA SINICA·Filed 2010·Application pending·0 cites
- 3934US2002102737A1Diagnostic methods for pompe disease and other glycogen storage diseasesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →